Locations
Vancouver, BC, Canada · north vancouver, bc, canada · North Vancouver, BC, Canada
industry
Biotechnology
Size
11-50 employees
Stage
Series A
founded in
2021
Gandeeva Therapeutics is a precision biotechnology company integrating the power of Cryogenic Electron Microscopy (CRYO-EM) and machine learning to develop differentiated therapeutics by targeting and modulating key protein-protein interactions. Gandeeva’s structure-guided drug discovery platform encompasses target prediction and validation (SPOTLIGHT™), hit identification by screening virtual and fragment libraries (HYPERFOCUS™), and lead optimization (CRYO-CADD™). Gandeeva has a robust preclinical oncology pipeline targeting difficult-to-treat cancers with novel protein interaction modulators such as interfacial glues (IGLUES™) and allosteric inhibitors. Gandeeva is headquartered in the Greater Vancouver area, Canada.
Something looks off?